Risk Factors for Coronary Heart Disease in Type 1 Diabetic Patients in Europe
Sabita S. Soedamah‐Muthu(The Royal Free Hospital), Gianpaolo Reboldi(Ca' Foncello Hospital), M. Toeller(Heinrich Heine University Düsseldorf), Nish Chaturvedi(Imperial College London), Christos Manes(Papageorgiou General Hospital), Georges Michel(Centre Hospitalier de Luxembourg), Barry Ferriss(Cork University Hospital), John Fuller(The Royal Free Hospital)
Cited by 252
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients
|Hypertension|2016|503